PDB13 BUDGET IMPACT ANALYSIS OF SAXAGLIPTIN FOR THE TREATMENT OF DIABETES MELLITUS TYPE 2 (T2D) PATIENTS IN THE BRAZILIAN PRIVATE HEALTH CARE SYSTEM
Abstract
Authors
E Barbosa E Ribeiro E Asano M Nita R Rached P Mantilla A Pimentel BM Donato E Rahal